Fresenius Medical Care Provides Earnings Guidance for the Full Year of 2015 and 2016
May 19 15
Fresenius Medical Care provided earnings guidance for the full year of 2015 and 2016. For the year 2015, the company announced that revenue is expected to increase by 10% to 12% in constant currency and net income by up to 5%.
For the year 2016, the company expects net income to grow by 15% to 20%, and revenue to increase by 9% to 12% in constant currency.
Fresenius Medical Care AG & Co. KGAA Launches multiFiltratePRO
May 19 15
Fresenius Medical Care AG & Co. KGaA has launched multiFiltratePRO, a therapy system for continuous renal replacement therapy, or CRRT, which is indicated for the treatment of acute kidney failure in critically ill patients at intensive care units.
Fresenius Medical Care AG & Co. KGAA Presents at 40th Annual Deutsche Bank Health Care Conference, May-06-2015 10:40 AM
May 3 15
Fresenius Medical Care AG & Co. KGAA Presents at 40th Annual Deutsche Bank Health Care Conference, May-06-2015 10:40 AM. Venue: The InterContinental Hotel, 510 Atlantic Ave, Boston, MA 02210, United States.
Fresenius Medical Care AG & Co. KGAA Reports Consolidated Unaudited Earnings Results for the First Quarter Ended March 31, 2015
Apr 30 15
Fresenius Medical Care AG & Co. KGAA reported consolidated unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported total net revenues were $3,959,927,000 against $3,563,592,000 a year ago. Operating income was $504,400,000 against $444,895,000 a year ago. Income before income taxes was $402,292,000 against $348,634,000 a year ago. Net income attributable to shareholders of FMC-AG&Co. KGaA was $209,548,000 or $0.69 fully diluted earnings per share against $205,462,000 or $0.68 fully diluted earnings per share a year ago. Net cash provided by operating activities was $447,270,000 against $112,294,000 a year ago. Purchases of property, plant and equipment was $201,196,000 against $199,631,000 a year ago. Acquisitions and investments, net of cash acquired, and purchases of intangible assets were $21,896,000 against $137,157,000 a year ago. Total EBITDA was $680 million against $612 million a year ago. Cash provided by operating activities is impacted by the profitability of its business, the development of its working capital, principally inventories, receivables. The increase in 2015 versus 2014 was mainly a result of the $115 million payment for the W.R. Grace bankruptcy settlement which occurred in the first quarter of 2014, the impact of other working capital items such as the timing related to the payment of payables and other liabilities as well as decreased inventory.